Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021Julia W. Gargano, Sara E. Oliver, John R. Su et al.|MMWR Morbidity and Mortality Weekly Report|2021Cited by 602
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance studyIan Kracalik, Jacek M. Mazurek, Matthew E. Oster et al.|The Lancet Child & Adolescent Health|2022Cited by 78